Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use

NEW BRUNSWICK, N.J., Feb. 27, 2021 /PRNewswire/ —¬†Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorizat‚Ķ [read more]

Leave a Comment